Jaguar Health (JAGX) Tax Provisions (2017 - 2019)
Jaguar Health (JAGX) reported Tax Provisions of $10000.0 for Q3 2019, up 101.01% quarter-over-quarter from -$990549.0 in Q4 2017.
Jaguar Health (JAGX) Tax Provisions (2017 - 2019) Analysis & Trends
Jaguar Health (JAGX) has 2 years of Tax Provisions data on file, last reported at $10000.0 in Q3 2019.
- Tax Provisions for Q3 2019 came in at $10000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2023 was $10000.0 (changed N/A YoY), and the FY2019 annual result was $10000.0, changed N/A from the prior year.
- Tax Provisions rose to $10000.0 in Q3 2019 per JAGX's latest filing, from -$990549.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $10000.0 in Q3 2019 and troughed at -$12.2 million in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 10,000.00 |
| Dec 31, 2017 | -990,549.00 |
| Sep 30, 2017 | -12.19 Mn |